Key Statistics
Market Cap$94.06M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.27
52W High$7.75
52W Low$3.71
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week+1.26%
3 Month-25.19%
1 Year-34.26%
FinancialsAnnual · QuiverQuant
Revenue$6.00M
Assets$41.26M
Liabilities$5.63M
Net Income$7.99M loss
About
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company is headquartered in Houston, Texas.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze COYA with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.
